Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
Diabetes mellitus (DM) and its vascular complications are the one of the most prevalent
 diseases in the state of Qatar. It is a multifactorial disease associated with the
 development of retinopathy, nephropathy, neuropathy, cardiomyopathy, and severe vascular
 dysfunction. The complications of diabetes are caused by either insulin deficiency (type 1
 DM) or insulin resistance (type II DM).Unfortunately, effective and sustainable prevention
 programs of diabetes are limited, and treatment options for type II DM are restricted.
 Current therapy is based upon control of blood glucose, cholesterol and triglycerides,
 primarily through insulin replacement in type I diabetes or oral hypoglycemic agents and/or
 insulin replacement in type II diabetes. New therapies able to prevent vascular complications
 of diabetes are needed to decrease the occurrence of end organ damage and improve the quality
 of life of the people. Safe and effective nutritional supplements that could be given along
 with the regular treatment of the patients that might reduce the need for insulin replacement
 therapy provide tighter glucose control and protect against oxidative stress and the vascular
 pathology associated with diabetes mellitus are the need of the hour. Our hypothesis is that
 supplementation of Taurine in the diets of diabetic patients might reduce the dose or need
 for insulin replacement therapy and protect them against oxidative stress that is responsible
 for the complications of diabetes mellitus.
Inclusion Criteria:

 1. Male or Female

 2. Above 18-65 Years of old

 3. Known diabetic patients with HbA1c>8.0%

 4. People who provide signed informed consent -

 Exclusion Criteria:

 -  1. Pregnancy 2. Diabetic patients with HbA1c <8.0 % 3. Recent or prospective surgical
 interventions 4. Complications of Type I and Type II DM, e.g., Active cardiovascular
 disease, nephropathy, retinopathy, neuropathy 5. People who do not provide signed
 informed consent